JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Depreciation & Amortization
JW (Cayman) Therapeutics Co Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Depreciation & Amortization
-¥74.9m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-132%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Depreciation & Amortization
-¥326.2m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Depreciation & Amortization
-¥186.6m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Depreciation & Amortization
-¥23.7m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
-74.9m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Depreciation & Amortization amounts to -74.9m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-132%
Over the last year, the Depreciation & Amortization growth was -54%. The average annual Depreciation & Amortization growth rates for JW (Cayman) Therapeutics Co Ltd have been -74% over the past three years , -132% over the past five years .